Astragalus Polysaccharide Shows Promise in Treating Dilated Cardiomyopathy | New Insights from Zebrafish Models

In this episode of SciBud, join host Maple as we dive into a captivating study harnessing the power of traditional Chinese medicine to tackle dilated cardiomyopathy (DCM), a serious heart condition where the heart's ability to pump blood is compromised. Discover how researchers investigated Astragalus polysaccharide (APS), a natural compound, in a zebrafish model engineered to mimic genetic mutations causing DCM, specifically the tnnt2a gene. Through innovative techniques like CRISPR/Cas9 and RNA sequencing, the study revealed that APS significantly improved heart function and increased survival rates by inhibiting programmed cell death in heart cells. While the findings are promising, the journey from lab to clinic still calls for further exploration. Tune in to learn more about this pioneering research, its implications for cardiac health, and how it opens new doors in the quest for effective treatments! Link to episode page with article citation: www.scibud.media/podcast/season/2025/episode/9